Contact

Payer

Pharma

Provider

Formulary guidance and transparency from P&T to point of care

Trends that Matter for Pharmaceutical Drug Development

Posted by Matt Breese on Jul 21, 2016

Find me on:

A collection of engaging infographics from healthcare influencers that reveals trends in pharmaceutical drug development cost and focus.

Since 2000, the average cost for pharmaceutical manufacturers to develop a new product increased significantly. Breakthrough therapies that once cost well below $1 billion to commercialize now cost 2 or 3 times more, according to Adherely.

adherely_infographic_design2-page-001-mmit.jpg

 

To put the chances of drug development failure in perspective, ePharmacology's graphic shows that out of the 10,000 compounds that enter drug discovery and the 250 that reach pre-clinical development, only 1 compound will reach commercialization. 

pipeline-development-mmit.jpg

 

The pharmaceutical research and development market sits around one-quarter of a trillion dollars, according to ISR reports. The same report also concludes that the smaller CRO market will grow over 7% to $34 billion over the next few years.

infographic-the-world-of-drug-development-trends-1-638-mmit.jpg

 

To understand where big pharma spends their drug development dollars, Adherely identifies the major cost drivers, including: buildings, administration fees, equipment, patent legality, trial fees, medical communication, software and promotion.

adherely_infographic_design2-page-001-mmit2.jpg

Subscribe to the MMIT blog for more insights on trends affecting pharmaceutical manufacturers, providers and payers.

Subscribe for Weekly Trends that Matter

Topics: Specialty, Industry Trends, Branding & Marketing